Conclusion
Patients with CRSwNP experience higher rates of asthma and lower rates
of URTIs but otherwise do not demonstrate significant socioeconomic,
comorbidity, lifestyle or quality of life issues other than for body
pain and alcohol consumption. In the future, as endotyping replaces the
current phenotypes and means of sampling larger sections of the
populations become easier, it will be useful to revisit these findings
through further epidemiological study.